DMD DiLab, Inc.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on June 6, 2007; DOI: 10.1124/dmd.107.015008


0090-9556/07/3509-1564-1573$20.00
DMD 35:1564-1573, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.015008v1
35/9/1564    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeng, Y.
Right arrow Articles by Yao, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeng, Y.
Right arrow Articles by Yao, X.

Isolation and Identification of Phase 1 Metabolites of Demethoxycurcumin in Rats

Yongchi Zeng, Feng Qiu, Yuan Liu, Gexia Qu, and Xinsheng Yao

Department of Natural Products Chemistry, Shenyang Pharmaceutical University, Shenyang, P. R. China

Curcuminoids are a safe natural food coloring additive with anti-inflammatory, antioxidant, and anticarcinogenic activities. Although demethoxycurcumin is one of the major bioactive constituents of curcuminoids, knowledge about its metabolic fate is scant. In the present study, four new metabolites, 5-dehydroxy-hexahydro-demethoxycurcumin-A (M-1), 5-dehydroxy-hexahydro-demethoxycurcumin-B (M-2), 5-dehydroxy-octahydro-demethoxy-curcumin-A (M-3) and 5-dehydroxy-octahydro-demethoxycurcumin-B (M-4), were isolated from feces of male Wistar-derived rats and from urine; three new metabolites, 5-O-methyl-hexahydrodemethoxycurcumin-A (M-7), 5-O-methyl-hexahydro-demethoxycurcumin-B (M-8), and 5-dehydroxy-dihydro-demethoxycurcumin-B (M-9), and two known metabolites, hexahydro-demethoxycurcumin-A (M-5) and hexahydro-demethoxycurcumin-B (M-6), were isolated. Their structures were established by chemical and spectral methods. ll of them were reductive metabolites. Possibly of greater importance is that they occurred as pairs of isomers with a methoxyl group substituted on a different benzene ring. This finding in the metabolism of curcuminoids is reported here for the first time. In addition, the 5-dehydroxy or 5-O-methylated metabolites are also a novel finding. The fact that the metabolites occurred as pairs of the isomers suggests that demethoxycurcumin possibly undergoes tautomerization between 3-keto-5-enol (form A) and 3-keto-5-enol (form B) in rats. Based on the metabolite profiles, metabolic pathways of demethoxycurcumin in rats are proposed.


Address correspondence to: Feng Qiu, Department of Natural Products Chemistry, Shenyang Pharmaceutical University, No. 103 Road Wenhua, Shenyang, P. R. China 110016. E-mail: fengqiu20070118{at}163.com







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.